Join Us as We Celebrate the Achievements of the Cannabis Industry This 4/20

by adminTorusBrand | Apr 19, 2017 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannaway

The cannabis community had much to celebrate this year. From the expansion of marijuana access to an increase in cannabis research, this amazing plant and the incredible industry that has sprung up around it has experienced unprecedented growth since last 4/20. There...

AXIM® Biotechnologies to Develop Chewing Gum with Bioequivalence to Marinol®

by adminTorusBrand | Mar 30, 2017 | Axim Biotechnologies, Company News, Scientific Research

[vc_row][vc_column][vc_column_text] AXIM® Biotechnologies, a major Medical Marijuana, Inc. investment company, has taken the first steps toward developing a chewing gum bioequivalent to Marinol, made using a synthetic version of THC or tetrahydrocannabinol. This week,...

Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol

by adminTorusBrand | Mar 28, 2017 | Axim Biotechnologies, Press Releases

[vc_row][vc_column][vc_column_text]SAN DIEGO, March 28, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech)...

AXIM Biotechnologies Partners with Ora, Inc. for Cannabinoid-Based Drug Development and Clinical Trials for Eye Conditions

by adminTorusBrand | Mar 23, 2017 | Axim Biotechnologies, Press Releases, Scientific Research

In order to fast-track approval of its new products, AXIM® Biotechnologies, Inc., a Medical Marijuana, Inc. investment company, has retained the services of Ora®, Inc. for the development of its cannabinoid-based eye treatments.   A global Contract Research...

Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications

by adminTorusBrand | Mar 21, 2017 | Axim Biotechnologies, Press Releases

NEW YORK, March 21, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM®Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in...

AXIM® Biotechnologies Starts Phase II Clinical Trial for IBS Treatment

by adminTorusBrand | Mar 7, 2017 | Axim Biotechnologies, Canchew, Company News

[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. investment company AXIM® Biotechnologies has announced it has completed enrollment of the required 40 patients for its Phase II clinical trial for CanChew Plus® CBD gum for the treatment of irritable bowel...